中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
32期
18-18,20
,共2页
胰岛素%降糖药%老年糖尿病%生存质量
胰島素%降糖藥%老年糖尿病%生存質量
이도소%강당약%노년당뇨병%생존질량
Insulin%Hypoglycemic drugs%Elderly diabetes%Life quality
目的:观察不同胰岛素联合口服降糖药对老年糖尿病患者生存质量的影响。方法:2013年4月-2014年4月收治老年糖尿病患者106例,将其随机分为研究组和对照组,每组53例,研究组行甘精胰岛素联合口服降糖药治疗,对照组行NPH基因重组人胰岛素联合口服降糖药治疗,比较两组餐后2 h血糖、空腹血糖、糖化血红蛋白水平以及生存质量。结果:研究组的餐后2 h血糖、空腹血糖以及糖化血红蛋白水平均比对照组低,且研究组的生存质量比对照组高,两组差异有统计学意义(P<0.05)。结论:甘精胰岛素联合口服降糖药治疗老年糖尿病可以控制患者的血糖,并可以提高患者的生存质量,值得临床推广。
目的:觀察不同胰島素聯閤口服降糖藥對老年糖尿病患者生存質量的影響。方法:2013年4月-2014年4月收治老年糖尿病患者106例,將其隨機分為研究組和對照組,每組53例,研究組行甘精胰島素聯閤口服降糖藥治療,對照組行NPH基因重組人胰島素聯閤口服降糖藥治療,比較兩組餐後2 h血糖、空腹血糖、糖化血紅蛋白水平以及生存質量。結果:研究組的餐後2 h血糖、空腹血糖以及糖化血紅蛋白水平均比對照組低,且研究組的生存質量比對照組高,兩組差異有統計學意義(P<0.05)。結論:甘精胰島素聯閤口服降糖藥治療老年糖尿病可以控製患者的血糖,併可以提高患者的生存質量,值得臨床推廣。
목적:관찰불동이도소연합구복강당약대노년당뇨병환자생존질량적영향。방법:2013년4월-2014년4월수치노년당뇨병환자106례,장기수궤분위연구조화대조조,매조53례,연구조행감정이도소연합구복강당약치료,대조조행NPH기인중조인이도소연합구복강당약치료,비교량조찬후2 h혈당、공복혈당、당화혈홍단백수평이급생존질량。결과:연구조적찬후2 h혈당、공복혈당이급당화혈홍단백수평균비대조조저,차연구조적생존질량비대조조고,량조차이유통계학의의(P<0.05)。결론:감정이도소연합구복강당약치료노년당뇨병가이공제환자적혈당,병가이제고환자적생존질량,치득림상추엄。
Objective:To observe the effect of different insulin combined with oral hypoglycemic drugs on the life quality in elderly patients with diabetes.Methods:106 elderly patients with diabetes were selected from April 2013 to April 2014.They were divided into the study group and the control group with 53 cases in each.The study group were treated with insulin glargine combined with oral hypoglycemic drugs.The control group were treated with NPH gene recombinant human insulin combined with oral hypoglycemic drugs.The postprandial 2 hours blood glucose,fasting blood glucose,glycosylated hemoglobin level and life quality of two groups were compared.Results:The postprandial 2 hours blood glucose,fasting blood glucose and glycosylated hemoglobin level of the study group were lower than those of the control group.The life quality of the study group was higher than that of the control group.The difference of two groups was statistically significant(P<0.05).Conclusion:Insulin glargine combined with oral hypoglycemic drugs in the treatment of elderly patients with diabetes can control blood glucose of patients and improve the life quality of patients.It is worthy of clinical promotion.